The authors’ conclude that DAs could potentially explain the weight loss alongside the metabolic advantages observed, stressing the importance of specifically screening prolactin (PRL) levels in men dealing with severe obesity. This evidence concerns the gene PRL and obesity due to melanocortin 4 receptor deficiency.